GHK-Cu vs Rusfertide
Overview
GHK-Cu is primarily a healing & recovery peptide, while Rusfertide is used for weight management & metabolic.
This page compares GHK-Cu and Rusfertide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| GHK-Cu | Rusfertide | |
|---|---|---|
| Category | Healing & Recovery | Weight Management & Metabolic |
| Regulatory status (US) | Compounding (Rx) — Apr 2026 | FDA approved |
| Typical dosage | 1-3 mg | 19-108 mg |
| Frequency | daily | once weekly, subcutaneous |
| Reported benefits | Wound healing, collagen synthesis, anti-inflammatory, antioxidant effects, tissue remodeling | In the Phase 3 VERIFY trial, adding rusfertide to standard-of-care therapy allowed 76.9% of participants to achieve hematocrit control without phlebotomy during weeks 20-32, compared with 32.9% on placebo plus standard of care. Reported benefits are specific to polycythemia vera erythrocytosis management and have not been studied for other conditions. |
| Reported side effects | Generally safe. Possible: mild skin irritation with topical use | Injection-site reactions (56%) and anemia (16%) were the most common adverse events in clinical trials; labeled warnings include thrombocytosis and embryo-fetal toxicity. |
Key differences
Primary use. GHK-Cu is categorised under Healing & Recovery, while Rusfertide falls under Weight Management & Metabolic. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. GHK-Cu: not FDA-approved; compounding permitted with a prescription as of April 2026. Rusfertide: FDA-approved.
Dosing. GHK-Cu is typically dosed at 1-3 mg (daily). Rusfertide is typically dosed at 19-108 mg (once weekly, subcutaneous).
Can you stack them?
Some protocols combine peptides, but stacking GHK-Cu and Rusfertide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between GHK-Cu and Rusfertide?
- GHK-Cu is primarily a healing & recovery peptide, while Rusfertide is used for weight management & metabolic. GHK-Cu is not FDA-approved; compounding permitted with a prescription (as of April 2026), whereas Rusfertide is FDA-approved for one or more indications.
- What is GHK-Cu used for?
- Wound healing, skin regeneration.
- What is Rusfertide used for?
- A once-weekly injectable hepcidin-mimetic peptide FDA-approved to treat erythrocytosis in adults with polycythemia vera.
- Can you take GHK-Cu and Rusfertide together?
- Some users combine peptides within a single protocol, but stacking GHK-Cu and Rusfertide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is GHK-Cu or Rusfertide FDA-approved?
- GHK-Cu is not FDA-approved; compounding permitted with a prescription (as of April 2026). Rusfertide is FDA-approved for one or more indications.
Read the full articles
- GHK-Cu — full monograph: mechanism, research, dosing & references
- Rusfertide — full monograph: mechanism, research, dosing & references